BriaCell Jumps 41% in U.S. Pre-market Trading, Reports Complete Lung Metastasis Resolution in Patient
In This Article:
BriaCell Therapeutics (BCT.TO), up 41% in U.S. pre-market trading, on Thursday confirmed the sustain
Upgrade to read this MT Newswires article and get so much more.
A Silver or Gold subscription plan is required to access premium news articles.